[Hemodynamic studies of pulmonary heart diseases and the effects of nifedipine]. 1994

W Q Wu, and Z S Rong, and X Q Yang
First Affiliated Hospital of Sun Yat-sen University of Medical Sciences, Guangzhou.

Swan-Ganz catheterization, blood gas analysis, pulmonary function tests and two-dimensional echocardiography were performed in 10 patients with pulmonary heart disease and the effects of nifedipine were then observed. Mean pulmonary artery pressure (mPAP) correlated significantly to PaO2. PaO2 may be a useful parameter for predicting mPAP. Continuous oxygen breathing can correct hypoxemia, prevent and alleviate pulmonary artery hypertension (PAH). After using nifedipine, PaO2 and blood pressure of systemic circulation decreased significantly, while pulmonary physiological shunt increased and pulmonary artery pressure did not decrease. As a consequence, the use of nifedipine to treat pulmonary heart disease and PAH is not advocated.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011660 Pulmonary Heart Disease Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM. Cor Pulmonale,Disease, Pulmonary Heart,Diseases, Pulmonary Heart,Heart Disease, Pulmonary,Heart Diseases, Pulmonary,Pulmonary Heart Diseases
D001784 Blood Gas Analysis Measurement of oxygen and carbon dioxide in the blood. Analysis, Blood Gas,Analyses, Blood Gas,Blood Gas Analyses,Gas Analyses, Blood,Gas Analysis, Blood
D002407 Catheterization, Swan-Ganz Placement of a balloon-tipped catheter into the pulmonary artery through the antecubital, subclavian, and sometimes the femoral vein. It is used to measure pulmonary artery pressure and pulmonary artery wedge pressure which reflects left atrial pressure and left ventricular end-diastolic pressure. The catheter is threaded into the right atrium, the balloon is inflated and the catheter follows the blood flow through the tricuspid valve into the right ventricle and out into the pulmonary artery. Catheterization, Pulmonary Artery,Swan-Ganz Catheterization,Pulmonary Artery Catheterization,Artery Catheterization, Pulmonary,Artery Catheterizations, Pulmonary,Catheterization, Swan Ganz,Catheterizations, Pulmonary Artery,Pulmonary Artery Catheterizations,Swan Ganz Catheterization
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

W Q Wu, and Z S Rong, and X Q Yang
January 1989, Revista paulista de medicina,
W Q Wu, and Z S Rong, and X Q Yang
January 1982, Giornale italiano di cardiologia,
W Q Wu, and Z S Rong, and X Q Yang
July 1983, Journal of the American College of Cardiology,
W Q Wu, and Z S Rong, and X Q Yang
September 1980, The American journal of cardiology,
W Q Wu, and Z S Rong, and X Q Yang
February 1990, Zhonghua xin xue guan bing za zhi,
W Q Wu, and Z S Rong, and X Q Yang
November 1986, Wiener klinische Wochenschrift,
W Q Wu, and Z S Rong, and X Q Yang
December 1979, Japanese circulation journal,
W Q Wu, and Z S Rong, and X Q Yang
December 1988, Cardiovascular drugs and therapy,
W Q Wu, and Z S Rong, and X Q Yang
January 1973, Bollettino della Societa italiana di cardiologia,
W Q Wu, and Z S Rong, and X Q Yang
September 1984, The American journal of cardiology,
Copied contents to your clipboard!